CERCA NEL SITO
Angeliq® is an oral, continuous combined hormone replacement therapy (HRT) containing 17β-estradiol 1 mg and the novel progesterone drospirenone (DRSP) 2 mg. Several large-scale trials have demonstrated the efficacy and safety of Angeliq® in almost 600 post-menopausal women.
Angeliq© - A new HRT
28/06/2007
Graziottin A.
Angeliq© - A new HRT
Proceedings of the 12th World Congress of Human Reproduction, International Academy of Human Reproduction, Venice, March 10-13, 2005
CIC Edizioni Internazionali, Roma, p. 694, 2005
Graziottin A.
Angeliq© - A new HRT
Proceedings of the 12th World Congress of Human Reproduction, International Academy of Human Reproduction, Venice, March 10-13, 2005
CIC Edizioni Internazionali, Roma, p. 694, 2005
